Full-Time

Medical Lab Scientist

Posted on 4/5/2025

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

No salary listed

Junior

Company Historically Provides H1B Sponsorship

Austin, TX, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
Inventory Management
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Natera referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • 1-2 years of experience as a Medical Technologist or equivalent in a clinical laboratory environment.
  • BS/BA degree in Medical Technology, Biological Sciences, or a related field
  • Current MT/MLS/CLS certification preferable from ASCP, AMT, or AAB.
Responsibilities
  • Verify the proper specimen being analyzed and perform tests that need to be completed
  • Proficient at analyzing clinical laboratory specimens following the standard methods and procedures in an efficient manner with little to no errors
  • Responsible for maintaining updated understanding and knowledge of methods performed in the lab
  • Provides general oversight of personnel and the daily operations in the lab
  • Meet expected performance metrics within the role as applicable
  • Follows GLP (good laboratory practice): maintain clean and organized workspace
  • Completes training and other deadlines on time
  • Provide guidance for new Clinical Laboratory Operators and/or Medical Laboratory Scientists
  • Train on specialized instructions for instruments/protocols (super users)
  • Recognizes and escalates equipment malfunctions; troubleshoots common analytical and processing errors according to the laboratory’s standard operating procedure
  • Recognizes, documents, and escalates protocol deviations in lab to lead/supervisor
  • Assists with documentation for nonconformance reports
  • Participates in the updating of departmental standard operating procedures and database to accurately reflect the current practices
  • Conducts independent continuous improvement projects
  • Ensures compliance with all regulatory agency requirements through proper documentation (example maintenance logs, bench worksheet)
  • Performs quality control procedures to ensure accuracy of clinical data (if applicable)
  • Maintains equipment and instruments in good operating condition (such as calibration and expiration date)
  • Maintain inventory of material, supplies and equipment in the laboratory for performance of duties
  • Communicates with team and other departments on various platforms (including via e-mail)
  • Provides feedback on day-to-day schedule and tasks to lead/supervisor; offers suggestions/ideas for improvement
  • Assists teammates in completing daily tasks and facilitate workflow as needed
  • Conducts himself/herself in a professional manner; acts as a role model/mentor to others
  • Adheres to Departmental Expectations
Desired Qualifications
  • Experience in Molecular Biology preferred
  • Excellent interpersonal, communication, computer, troubleshooting, and pipetting skills
  • Excellent oral and written communication skills
  • Word processing and data management skills
  • Ability to work well in a group
  • Ability to work independently, with minimal supervision

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and monitor organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing services and kits, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's custom-built ctDNA tests.

What critics are saying

  • Increased competition from companies like Lantheus Holdings threatens market share.
  • Recent CFO stock sale may indicate concerns about Natera's financial health.
  • Multiple trial launches could strain resources and lead to operational challenges.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical needs.
  • Their Signatera test offers custom-built ctDNA solutions for cancer patients.
  • Natera's Panorama NIPT has achieved over 2 million tests conducted.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 5%
TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.

Simply Wall St
Mar 13th, 2025
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.

Investing.com
Mar 10th, 2025
Natera launches HEROES trial for breast cancer treatment

Natera launches HEROES trial for breast cancer treatment.

INACTIVE